LUMEDX Blog 

ONC report says success of AI in healthcare hinges on good data

Without access to high-quality, reliable data, artificial intelligence will not fulfill its promise to help shape the future of public health, community health and healthcare delivery, according to a new report by JASON.

The study, "Artificial Intelligence for Health and Health Care," focuses on the technical capabilities, limitations and applications for AI in healthcare that can be realized in within the next 10 years. It says that while the availability of digital health data could allow for AI functionality in clinical practice, the quality of existing data remains a problem.

According to the study, society has been primed and the time is ripe for AI’s use in healthcare thanks to three forces:

  1. Frustration with the existing–or legacy–medical systems among patients and health professionals.
  2. Ubiquity of networked smart devices in society.
  3. Comfort with at-home services like those provided through Amazon and other technology companies.

In addition, the study offers recommendations for next steps that could accelerate the use of AI in and out of the clinical setting. They include understanding AI’s limitation in the arenas of health and healthcare. To read the full report, click here.

The study was commissioned by the Office of the National Coordinator for Health IT (ONC) and the Agency for Healthcare Research and Quality (ARHQ), with support from the Robert Wood Johnson Foundation. JASON is an independent group of scientists and academics that has been advising the federal government on science and technology issues for more than 50 years.

We at LUMEDX are thrilled with the promise AI has shown to improve the overall quality of healthcare and committed to helping hospitals gather and analyze the kind of high-quality cardiovascular data needed to get better outcomes at lower costs. To this end, LUMEDX recently released the new HealthView Analytics and is currently piloting embedded workflow analytics. Learn more by visiting www.lumedx.com/healthview-analytics or email us at info@lumedx.com.

Posted by Jana Ballinger Tuesday, April 10, 2018 1:39:00 PM Categories: AI analytics artificial intelligence ONC

LUMEDX Blog 

300 attend webinar to plan for ACC CathPCI v5 update

With the American College of Cardiology’s update of the NCDR® CathPCI Registry® to version 5 fast approaching, 300 LUMEDX users attended our third and final informational webinar earlier this week to prepare clients for a smooth transition. Our first and second webinars were attended by a total of 125 users. Thank you all!

The mandatory CathPCI v5 update goes into effect April 1. As part of your valid Support and Maintenance Agreement, you will be provided with the required updated LUMEDX software components.

Because there have been extensive changes to what the ACC is requiring, and hemodynamic interfaces will be impacted, we wanted to offer pre-planning sessions to assist our clients in their preparation. We are excited to have had so many clients participate in our CathPCI v5 planning session, which answered questions including:

  • How do I determine the scope of the upgrade for my site?
  • How can I prepare now for the update?
  • What should I do after the update is released?
  • What about any customizations made in version 4.4?

If you missed the webinar or simply want to hear it again, a recording can be found by logging in to the Forum page here. Email any further questions to info@lumedx.com or contact your Client Success Manager.

Posted by Jana Ballinger Wednesday, March 14, 2018 3:13:00 PM Categories: ACC American College of Cardiology CathPCI registries

LUMEDX Blog 

Health IT spending study identifies value-based care, analytics as top priorities

Healthcare providers are prioritizing value-based payment models in 2018 IT budgets and data analytics is the category most likely to see an increase in spending, according to a survey from healthcare advisory firm Damo Consulting.

According to the study, the biggest drivers of technology spending in the healthcare sector are value-based care initiatives (60.5 percent), patient engagement and care management (57.9 percent), enterprise digital transformation (47.4 percent), and considered cybersecurity and ransomware (39 percent).

The study also asked respondents which technology areas they think will see increased spending in 2018. Data analytics was the single biggest area identified, with 76.3 percent. Nearly half (47.4 percent) believe that AI and cognitive spending will increase in 2018, followed by digital health (44.7 percent).

When questioned about the biggest obstacles for growth in healthcare IT spending, a majority (60.5 percent) of respondents cited a lack of enterprise readiness for new technologies. Fifty percent of respondents believe interoperability challenges to be the second biggest obstacle and 47.4 percent indicated insufficient/unproven ROI on new IT solutions.

Among the other findings is that the CIO remains the most important decision maker (23.7 percent) for technology solutions and services in their client organization. However, other titles are gaining importance, such as CFO, CTO and CMIO.

Damo sought input from 38 individuals at global technology firms, population health management companies, digital health organizations and more. To read more, download the survey here.

At LUMEDX, we know that analytics and value-based care go hand in hand. Actionable insights from your data are key for health organizations making the transition from a fee-for-service payment model. For more information about how our HealthView Analytics offering can help you, visit lumedx.com/healthview-analytics or email info@lumedx.com.

LUMEDX Blog 

Visit LUMEDX at ACC.18 and NCDR.18 in Orlando

Join LUMEDX at the American College of Cardiology 67th Annual Scientific Session & Expo (ACC.18)—the largest gathering of innovative cardiovascular products and services under one roof—and the National Cardiovascular Data Registry Annual Conference (NCDR.18), a 2½-day program held right before ACC.18 that aims to help hospitals and health systems blaze trails in quality improvement.

During ACC.18, LUMEDX will be at Booth 3007 in the Interventional Pavilion, showcasing our cutting-edge software and services designed to help hospitals improve care and reduce costs across the cardiovascular service line. Schedule a meeting here to learn all about the latest CV data management tools and our new analytics-driven Cardiovascular Performance Program.

ACC.18 is March 10-12 at the Orange County Convention Center in Orlando, Florida. Expo hours are 9:30 a.m.-4:45 p.m. Saturday and Sunday, March 10-11, and 9:30 a.m.-2 p.m. Monday, March 12. The conference features content in 11 learning pathways, each narrowing in on a different clinical specialty of cardiovascular disease, including Interventional Cardiology, Congenital Heart Disease, Prevention and more.

An estimated 13,000 healthcare professionals will attend the event that is packed full of networking opportunities and chances to discuss and debate the latest science and information with the world’s top experts. For more information about ACC.18, click here.

If you are attending NCDR.18, be sure to stop by the LUMEDX table to see how the No. 1 independent provider of ACC-NCDR® registry software can help your hospital go beyond data collection with innovative ways to drive quality and contain costs.

NCDR.18 will be held March 7-9 at the Caribe Royale Orlando and is expecting a turnout of 1,700 registry professionals, quality improvement professionals, physicians and administrators. Exhibit hours are 5:30-8:30 p.m. Wednesday, March 7, 6:30 a.m.-7 p.m. Thursday, March 8, and 7 a.m.-2:45 p.m. Friday, March 9. For a complete agenda, click here.

Posted by Jana Ballinger Tuesday, February 20, 2018 9:51:00 AM Categories: ACC American College of Cardiology analytics cardiology health information technology health IT healthcare analytics HIT NCDR

LUMEDX Blog 

LUMEDX showcases data intelligence tools at HIMSS18

LUMEDX will be demonstrating its powerful analytics and data management tools at the HIMSS Annual Conference & Exhibition, where more than 45,000 healthcare professionals from more than 90 countries will gather for the premier health information and technology conference.

Scheduled for March 5-9 at the Venetian-Palazzo-Sands Expo Center in Las Vegas, HIMSS18 is a one-stop shop for the education, innovation and collaboration professionals need to continue the transformation of healthcare through IT.

Come by Booth 12340, Level 1, Hall G, to learn how LUMEDX’s data intelligence solutions can help achieve better performance while reducing costs. Click here to schedule a demonstration of how meaningful analytics can monitor, measure and improve all aspects of cardiovascular services.

Exhibition Hall hours are limited to 9:30 a.m.-6 p.m. Tuesday and Wednesday, and 9:30 a.m.-4 p.m. Thursday.

Throughout the conference, HIMSS18 will include a full slate of networking opportunities, five keynote addresses, government sessions, specialty education tracks and more. Data Analytics/Clinical and Business Intelligence is one of 23 in-depth topics that will be explored in the 300-plus educational sessions being offered.

Other subject matters to be tackled include:

  • Improving Quality Outcomes Through Health IT
  • Health Information Exchange, Interoperability and Data Integration
  • Privacy, Security and Cybersecurity
  • Emerging Payment Models for Value-Based Care
  • Process Improvement, Workflow, Change Management

For more information about educational sessions, keynote speakers or registration, please visit www.himssconference.org.

Posted by Jana Ballinger Monday, February 12, 2018 9:25:00 AM Categories: analytics data healthcare analytics HIMSS

LUMEDX Blog 

Value-based care is here to stay, will get boost from analytics, study says

Despite 2017’s cancellation of mandatory bundled payments, the value-based care movement in the United States is still healthy and will benefit in 2018 from analytics, according to a report from Washington, D.C.-based healthcare consulting firm Avalere.

In “2018 Healthcare Industry Outlook,” Avalere says new ways to collect data and advanced analytic capabilities are revitalizing efforts to turn data into insights that can inform policy and improve clinical workflows. This supports the shift to value-based care, which has continued even as the Trump administration backs away from large-scale mandatory models.

In November, the Centers for Medicare and Medicaid Services (CMS) canceled a plan for mandatory hip fracture and cardiac bundled payments that was slated to go into effect Jan. 1, sparking some concern that the action signaled a move away from value-based care. But then on Jan. 9, the CMS launched a new, voluntary bundled payment model that will be considered an alternative payment model (APM) for purposes of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) reporting.

This, along with evidence from Avalere that the private sector has not reversed course, tells us that interest in strategies to move away from the traditional fee-for-service payment model has not waned.

“Despite political transitions and revisions to Medicare bundled payment programs, the U.S. healthcare system’s transition to APMs has remained steady,” the report says. In 2017, some of the largest commercial plans were running nearly 50 percent of their medical spend through APMs and aim to go higher, according to Avalere.

Because value-based care rewards healthcare providers who prioritize better outcomes for their patients, leaders are turning to technology investments that can lower costs and improve care quality. Avalere says that data reliability and accessibility, including capturing information and creating algorithms, will drive outcomes-based contracting and a transition toward APMs.

“Success in APMs will require providers to create better infrastructure for proactive care management, data analytics, and timely integration of disparate data,” the report says. “More widespread availability of real-world data will enable new entities to leverage analytics and insight to benefit patients and their providers.”

An outcomes-driven environment requires fast and easy access to clinical and financial intelligence that can shine a light on the best possible course forward. To learn how LUMEDX data analytics can help your organization in the transition to value-based care by becoming more efficient and improving patient satisfaction, get information about the Cardiovascular Performance Program or email us at info@lumedx.com.

LUMEDX Blog 

Health execs hopeful about big data and analytics, new study says

​Hospital executives are optimistic that big data and analytics will achieve broader adoption in healthcare over the next two years, helping organizations maximize their return on IT investments, according to a new study by SAP and Oxford Economics.

Technology is dramatically affecting the healthcare industry and delivering new value, says the study, “Digital Transformation in Healthcare: A Positive Prognosis,” which surveyed nearly 400 hospital executives. Growth, competitive advantage and customer experience depend on the latest technologies, according to 70 percent of respondents.

Asked about specific technologies likely to achieve broader adoption over the next two years, 76 percent of healthcare leaders predicted big data and analytics, 65 percent cited cloud computing, 46 percent named the Internet of Things (IoT) and 28 percent said artificial intelligence (AI).

What might all this mean for cardiac and vascular departments? At LUMEDX, we have seen the shift to value-based payment models and the increasing importance of patient experience result in a greater reliance on data among our customer base—and a greater need for more sophisticated data analytics.

As tools and technologies evolve, we think cardiovascular service lines can be at the forefront of the digital transformation in healthcare. Performance analytics, highly efficient cardiovascular workflows, and optimal integration of clinical and operational data help our clients improve outcomes, radically reduce costs and increase revenue contribution to the hospital. To learn more, read about LUMEDX’s Cardiovascular Performance Program.

Posted by Jana Ballinger Thursday, January 04, 2018 9:37:00 AM Categories: analytics healthcare analytics performance

LUMEDX Blog 

PCICS: LUMEDX unveils solutions to support excellence in pediatric cardiology data intelligence

The Pediatric Cardiac Intensive Care Society (PCICS) is holding its 13th Annual International Meeting and LUMEDX will be there to share the latest in data intelligence and workflow management tools to support better care of pediatric and congenital cardiac patients.

Come see us at Booth 11 to learn how we can help your pediatric heart center improve outcomes and reduce costs, drive better care through the use of benchmarks and evidence-based medicine, and create a more complete, patient-focused congenital database.

Exhibit hours are limited to 7 a.m. to 7 p.m. Thursday, Dec. 7, and 7-10:10 a.m. Friday, Dec. 8. Click here to schedule a meeting with a LUMEDX representative.

The conference, hosted by the Children’s National Health System, will be held Dec. 6-8 at the Fairmont-Georgetown in Washington, D.C.

A full schedule of roundtable discussions and sessions will focus on topics including:

  • How care delivery models around the world impact management of congenital heart disease.
  • The impact of medical missions and sustainable program development in low/middle income countries.
  • Cutting edge innovation—specifically device and drug development, machine learning technology, and education platforms—that are shaping pediatric cardiac critical care around the world.

For more information, go to www.pcics.org.

Posted by Jana Ballinger Monday, November 27, 2017 11:04:00 AM Categories: PCICS pediatric and congenital

LUMEDX Blog 

LUMEDX at RSNA 2017: Visit Booth 6235 for the latest in CV data intelligence

​Come see LUMEDX at the upcoming 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago and get the most up-to-date information about our cardiovascular service line and data intelligence tools.

RSNA 2017 will be held Nov. 26-Dec. 1 at the McCormick Convention Center. LUMEDX will be at Booth 6235, North—Hall B. The exhibition hall will be open 10 a.m. to 5 p.m. Nov. 26-29 and from 10 a.m. to 2 p.m. Nov. 30. About 25,000 attendees and 500 technical exhibitors are expected to attend the conference.

Learn more about our cardiovascular data intelligence offerings, which includes innovative software and services to help streamline care delivery, improve outcomes and dramatically reduce costs. Demos of LUMEDX’s powerful PACS and data management tools will also be available.

To schedule a meeting or demo, please click here.

Posted by Jana Ballinger Monday, November 20, 2017 10:27:00 AM Categories: analytics cardiology PACS

LUMEDX Blog 

Full-scale adoption of AI still a long way away, new study says

While the use of clinical and business intelligence tools is on the rise in healthcare, the hype surrounding artificial intelligence is unlikely to lead to full-scale adoption for quite some time, according to a new study by the Healthcare Information and Management Systems Society (HIMSS).

In the HIMSS 2017 Essentials Brief: Clinical and Business Intelligence, 23.5 percent of respondents said they expect their organizations to begin using AI within two years, 24.7 percent said within the next three to five years and 8.2 percent said six to 10 years. Only 4.7 percent said their organizations were already using AI and just 10.6 percent said they expect their organizations to begin leveraging AI within the next 12 months.

The prevailing belief seems to be that the technology just isn’t ready yet. Some 37 percent of respondents said further AI development is needed, 23.5 percent said the business case for AI was still unproven and 19.8 percent cited infrastructure constraints within their organizations. When questioned about barriers in the industry overall, 50 percent of respondents said they believe the technology is still in development and current opportunities to apply it to healthcare are difficult to understand.

Here are some of the other findings:

  • Clinical and Business Intelligence solution adoption rates for the U.S. healthcare market in 2017 are 48 percent and 62 percent, respectively.
  • Data governance, an important pre-requisite for the success of data analytics, has shown significant improvement in the “highly optimized” and “strong” categories from study respondents who were asked to qualify their efforts in this area.
  • While leveraging clinical analytics to meet Meaningful Use (MU) requirements and reporting remains the primary area of focus (nearly 70 percent of respondents), there has been an increase in the focus on population health year over year from roughly 20 percent in 2016 to 30 percent in 2017.

To learn more about the HIMSS findings, download the study here.

Clinical and financial business intelligence solutions have become essential to healthcare organizations in the move from volume to value-based care and in the development of new models of care. LUMEDX offers comprehensive, integrated cardiovascular data intelligence and imaging solutions—all with seamless connectivity to your enterprise systems (EHR/HIS).

For more information, download the Cardiovascular Performance Program Info Pack.

Posted by Jana Ballinger Monday, November 13, 2017 10:23:00 AM Categories: analytics data EHR HIMSS value-based purchasing
Page 1 of 22 1 2 3 4 5 6 7 8 9 10 > >>
  • RSS

Statistics

  • Entries (232)
  • Comments (806)

Categories